Covestor LTD Chemo Centryx, Inc. Transaction History

Covestor LTD

  • $160 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$22.17 - $51.8 $44 - $103
-2 Reduced 20.0%
8 $0
Q2 2022

Aug 10, 2022
SELL
$15.36 - $27.51 $46 - $82
-3 Reduced 23.08%
10 $0
Q1 2022

May 13, 2022
SELL
$22.22 - $39.12 $66 - $117
-3 Reduced 18.75%
13 $0
Q4 2021

Feb 10, 2022
BUY
$18.38 - $40.5 $294 - $648
16 New
16 $1,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email